Trine Grantzau

783 total citations
9 papers, 556 citations indexed

About

Trine Grantzau is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology. According to data from OpenAlex, Trine Grantzau has authored 9 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Trine Grantzau's work include Breast Cancer Treatment Studies (5 papers), Breast Lesions and Carcinomas (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Trine Grantzau is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Breast Lesions and Carcinomas (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Trine Grantzau collaborates with scholars based in Denmark. Trine Grantzau's co-authors include Jens Overgaard, Lene Mellemkjær, Mette S. Thomsen, Michael Væth, Inger Højris, Birgitte Vrou Offersen, Marie Overgaard, Hanne Melgaard Nielsen, Jan Alsner and Trine Tramm and has published in prestigious journals such as Blood, Radiotherapy and Oncology and Apmis.

In The Last Decade

Trine Grantzau

7 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Trine Grantzau Denmark	5	338	196	188	181	149	9	556
Thi Trinh Thuc Vu Canada	5	515 1.5×	343 1.8×	139 0.7×	124 0.7×	346 2.3×	7	746
N. Twyman United Kingdom	12	417 1.2×	395 2.0×	143 0.8×	204 1.1×	272 1.8×	25	677
Jarosław Łyczek Poland	7	417 1.2×	230 1.2×	175 0.9×	149 0.8×	97 0.7×	23	583
Carla De Luca Cardillo Italy	6	302 0.9×	167 0.9×	169 0.9×	99 0.5×	99 0.7×	21	442
Tanja Marinko Slovenia	10	423 1.3×	281 1.4×	191 1.0×	178 1.0×	244 1.6×	17	670
Adam Currey United States	13	288 0.9×	225 1.1×	142 0.8×	165 0.9×	215 1.4×	50	583
Péter Ágoston Hungary	9	187 0.6×	197 1.0×	61 0.3×	109 0.6×	103 0.7×	29	444
Kristina Lössl Switzerland	9	194 0.6×	188 1.0×	55 0.3×	120 0.7×	111 0.7×	25	451
Tanya Berrang Canada	11	437 1.3×	313 1.6×	168 0.9×	130 0.7×	199 1.3×	29	653
Katherine L. Griem United States	13	371 1.1×	314 1.6×	149 0.8×	156 0.9×	167 1.1×	24	640

Countries citing papers authored by Trine Grantzau

Since Specialization

Citations

This map shows the geographic impact of Trine Grantzau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trine Grantzau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trine Grantzau more than expected).

Fields of papers citing papers by Trine Grantzau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trine Grantzau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trine Grantzau. The network helps show where Trine Grantzau may publish in the future.

Co-authorship network of co-authors of Trine Grantzau

This figure shows the co-authorship network connecting the top 25 collaborators of Trine Grantzau. A scholar is included among the top collaborators of Trine Grantzau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trine Grantzau. Trine Grantzau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Grantzau, Trine, Mia Dahl Sørensen, Michael Møller, et al.. (2025). Reduced CD20 expression yields inferior survival in patients with B-cell lymphoma treated with CD20×CD3 antibodies. PubMed. 2(3). 100096–100096.

Grauslund, Morten, Lene Dissing Sjø, Linea Cecilie Melchior, et al.. (2024). NOTCH1 Mutations Are Associated with Therapy-Resistance in Patients with B-Cell Lymphoma Treated with CD20xCD3 Bispecific Antibodies. Blood. 144(Supplement 1). 1594–1594. 1 indexed citations

Julin, Carol M., Signe Ledou Nielsen, Trine Grantzau, et al.. (2024). Localized blastic plasmacytoid dendritic cell neoplasm associated with progressive clonal hematopoiesis and myelodysplastic syndrome. Apmis. 133(1). e13486–e13486.

Overgaard, Marie, Hanne Melgaard Nielsen, Trine Tramm, et al.. (2022). Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial. Radiotherapy and Oncology. 170. 4–13. 31 indexed citations

Grantzau, Trine, et al.. (2022). PD‐L1 expression and FGFR‐mutations among Danish patients diagnosed with metastatic urothelial carcinoma: A retrospective and descriptive study. Apmis. 130(8). 498–506. 2 indexed citations

Grantzau, Trine & Jens Overgaard. (2016). Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients. Radiotherapy and Oncology. 121(3). 402–413. 92 indexed citations

Grantzau, Trine & Jens Overgaard. (2014). Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients. Radiotherapy and Oncology. 114(1). 56–65. 149 indexed citations

Grantzau, Trine, Mette S. Thomsen, Michael Væth, & Jens Overgaard. (2014). Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiotherapy and Oncology. 111(3). 366–373. 151 indexed citations

Grantzau, Trine, Lene Mellemkjær, & Jens Overgaard. (2013). Second primary cancers after adjuvant radiotherapy in early breast cancer patients: A national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiotherapy and Oncology. 106(1). 42–49. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact